Charlotte (1)

Antibiotic Resistant Infection (1)

Carbapenem-Resistant Enterobacteriaceae Infection (1)

Gram-Negative Bacterial Infections (1)

KPC (1)

Recruiting (1)

phase 4 (1)

Wake Forest University Health Sciences (1)

Merck Sharp & Dohme LLC (1)

imipenem+relebactam (1)

drug (1)

Other (1)

Interventional (1)

kpc

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jun 16, 2022